Stem Cell Research Policy

Stem cell research is a development field of modern policy. A number of invoices have been proposed and several invoices have been passed on this point. Stem cells are multipotent, meaning that they can be transformed into other cells. These cells may treat and cure many diseases, which is not an option. Most controversies on stem cell research include moral opposition. Human embryonic stem cells were first removed in 1998. Until recently, these cells were acquired through human embryos.

The stem cell research policy approach includes eight state regulations in California, Connecticut, Illinois, Iowa, Maryland, Massachusetts, New Jersey, and New York. The law strictly prohibits embryos from studying their sources. Countries that specifically permit the study of embryonic stem cells have developed guidelines for scientists, including consent requirements and procedures for project approval and review. Table 2 summarizes state laws related to studies and research on human tissue purchase / sale restrictions.

Discussions on embryonic stem cell research need to consider various ethical and policy issues. Many of the ethical and policy issues of stem cell research apply to common biomedical research such as questions on the priority of appropriate research and limited resource allocation for research and health care. In this sense, discussion on stem cell research provides the opportunity to study various ethical and policy issues arising from biomedical innovation. In this article we will place stem cell research in a wider ethical and policy situation by explaining three more noteworthy considerations in the discussion. These include: (1) truth and scientific integrity; (2) prioritization of research and allocation of health resources; (3) citizen's discretionary responsibility for bioethical disputes

In 2009, President Obama overturned Bush 's stem cell policy to expand the amount of stem cell factors available to researchers. Policy makers are now working on new questions. Should the law governing other types of pluripotent stem cells be different from hES cell law? If so, what kind of new law is required?

There are three types of stem cells: embryonic stem cells, adult stem cells, artificial pluripotent stem cells (iPS). The most famous type of stem cells are embryonic stem cells. This is due to the extensive coverage of such stem cells by the media and the many judiciary laws developed based on their use. Because they are the most flexible stem cell types, they are also popular among researchers. Unlike their more mature counterparts, they have the ability to regenerate all types of cells. Embryonic stem cells are found in two areas: umbilical cord and embryo. Embryonic stem cells are found in blood taken from umbilical cord immediately after birth. It contains hematopoietic stem cells that can be used to produce erythrocytes; among other things. There are also mesenchymal stem cells that can be used to grow muscle and bones. Hematopoietic cells are used for the treatment of blood related diseases such as autoimmune diseases and leukemia